Canada: Drug Advertising In The Context Of Social Media

Last Updated: January 25 2016
Article by Anushua Nag and André Rivest

Both in the U.S. and in Canada, advertising of prescription pharmaceutical products is highly regulated and can raise various challenges, which are heightened in the context of social media. The reason prescription pharmaceutical product ads are so widely found on American television is simple: the Unites States, along with New Zealand, are the only two countries to allow direct broadcasting of such advertisements to the general public (Direct-to-consumer/DTC advertising).  On the other end of the spectrum, Canadian law prohibits all direct-to-consumer ads for narcotics or controlled drugs.  As for prescription drug advertisements, they are limited to displaying only certain statutorily prescribed information.  However, since these regulations were developed in the context of traditional media, applying them is proving more complicated in the era of social networks, whether in Canada or in the U.S.  Restrictions on the number of characters, for example, can be quite mind-boggling when attempting to present all of the potential side effects associated with a drug!1

In Canada, pharmaceutical product advertisement is mainly regulated by the Food and Drugs Act (the "Canadian Act").  The basic rule of the Canadian Act states that no person shall advertise any drug in a manner that is false, misleading or deceptive, or is likely to create an erroneous impression regarding its character, value, quantity, composition, merit or safety.  Although direct-to-consumer advertising of prescription drugs is allowed, the Canadian Act prohibits anyone from presenting such drugs to the general public as being a treatment, preventative or cure for any of the diseases, disorders or abnormal physical states referred to in Schedule A.  Schedule A lists a wide range of medical conditions, from chronic anxiety to congestive heart failure.  Further, a prescription drug advertisement must limit itself to presenting information that is statutorily prescribed, such as the brand name, common name, true name, price and quantity of the drug.  These rules are less stringent in certain regards, particularly with respect to biologic drugs and over-the-counter drugs, but that is largely beyond the scope of this article. Also of note, the Canadian Act does not prohibit the broadcast of informational messages pertaining to a particular drug when such messages do not set out the product benefits or use.  In fact, insofar as they are not associated with a medical condition referred to in Schedule A, such messages (or help-seeking advertisements) are theoretically allowed.

Although it is clear that the above regulations apply to all forms of advertisement, no matter the broadcasting medium used, applying these rules to new media platforms is causing some confusion.  In the recent years, Advertising Standards Canada (ASC), the national not-for-profit advertising self-regulatory body, released a short checklist on the advertising of drugs directly to the general public in which it simply reminded companies that all advertisements, even when broadcasted on social networks, must include the information required under the Canadian Act.

In the U.S., pharmaceutical product advertisement is mainly regulated by the Food and Drug Administration (FDA) under the Food, Drug and Cosmetic Act (the "US Act").  The great importance attached to the constitutional protection of freedom of expression is one of the main reasons direct-to-consumer advertising of pharmaceutical products is authorized, but advertising agencies are not granted blanket authority with this regard.  Print ads, in addition to being truthful and non-misleading, must mandatorily contain certain information, including: i) the established name and commercial name of the drug; ii) their ingredients and quantities; and iii) a brief description of the side effects, contraindications and effectiveness associated with using the drug. There must also be a proper balance in the way the side effects, contraindications and effectiveness are presented. As for television and radio ads, the US Act provides that they may include only a brief disclosure of the main risks associated with the drug, as long as such ads provide a toll-free number that consumers may call to get full disclosure of this information.

In respect of social media, in its guidelines issued in June of 2014, the FDA advised that a company deciding to present the benefits of a certain drug must also make sure to set out the risks associated with that drug, no matter what limitations may be imposed by a social media platform with regards to the number of characters.  The FDA also urged companies to provide consumers access to more detailed information about the risks associated with using the product (by providing a link to a more detailed website, for example).  

As shown above, the rules related to the advertising of pharmaceutical products in Canada vary considerably from the rules applicable in the U.S. However, considering the free flow of information on social networks and the speed at which it travels on these platforms, messages originating in the U.S. will inevitably end up on Canadian consumers' home pages. Although this spillover may be concerning, considering the more permissive nature of the U.S. rules, it is currently not monitored. Health Canada has stated that it has no jurisdiction over messages originating from the U.S., whether these messages are transmitted via traditional or new media.

In the absence of any specific rules applicable to drug advertising in the context of social media, pharmaceutical companies wishing to advertising their products on the various new platforms must rely on general advertising rules and make sure to apply them integrally. A good practice would be to closely monitor any further guidance on this topic provided by Health Canada and the FDA. We will keep you updated on future developments.

Footnotes

1 Let us first note that this article focuses on product claim ads (as opposed to reminder ads, for example, which make no reference to a drug's effectiveness).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Events from this Firm
17 Dec 2016, Other, Ontario, Canada

Podcast summary

In the inaugural episode of Diversonomics, co-hosts Roberto Aburto and Sarah Willis introduce listeners to the podcast and discuss their experiences with diversity and inclusion in the legal industry. They also outline some of the obstacles the profession faces with respect to adopting new strategies and overhauling old practices.

22 Dec 2016, Other, Toronto, Canada

Podcast summary

For episode two of Diversonomics, co-hosts Roberto Aberto and Sarah Willis interview Mark Greenburgh, a partner in Gowling WLG's London office. They discuss the exciting new diversity and inclusion opportunities that have arisen since the combination of Gowlings and Wragge Lawrence Graham, as well at Gowling WLG UK's LGBT OpenHouse initiative.

28 Dec 2016, Webinar, Toronto, Canada

Podcast summary

In episode three of Diversonomics, co-hosts Roberto Aburto and Sarah Willis interview Lorna Gavin, Gowling WLG U.K.’s head of diversity, inclusion and corporate responsibility. In their discussion, they explore the challenges and opportunities of implementing diversity and inclusion strategies across a global firm, while also detailing Gowling WLG U.K.’s various diversity networks.

 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.